Skip to main content
    P

    Pro-Dex Inc (PDEX)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $65.66
    -1.76 (-2.61%)

    Market Cap: $210.11M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Pro-Dex Inc (PDEX) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Pro-Dex (PDEX) trades at 18.0x trailing earnings and 2.7x sales. Its P/E of 18.0x is above its 5-year median of 17.6x. Its forward P/E is 21.2x. The median P/E across 3 similar companies is 21.7x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 15.1% lower over the next year. Its free cash flow yield is 3.2%.

    MultipleValue
    P/E (trailing)18.0x
    Forward P/E21.2x
    Price to sales2.7x
    Price to book4.4x
    EV/EBITDA12.5x
    Price to FCF31.3x
    EV/FCF32.7x
    PEGN/A
    FCF yield3.2%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 11.8% above 16.1x, its P/S is 50.0% above 1.8x and its P/B is 46.7% above 3.0x.

    MultipleCurrent5-year median10-year median
    P/E18.0x17.6x16.1x
    P/S2.7x1.6x1.8x
    P/B4.4x2.8x3.0x
    Medians of month-end values through Oct 2026: 59 to 60 months (5-year) and 119 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 4.8x in 2016 to 23.4x in 2023.

    Year endPriceP/EP/SP/B
    2025$38.4811.8x1.8x3.0x
    2024$46.7523.3x2.6x4.8x
    2023$17.5223.4x1.3x2.0x
    2022$15.9015.3x1.3x2.3x
    2021$23.2118.6x2.1x3.9x
    2020$30.9723.3x3.3x5.5x
    2019$17.5518.3x2.5x3.9x
    2018$12.0814.0x2.1x3.0x
    2017$6.8011.0x1.2x1.8x
    2016$4.704.8x1.0x1.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PDEX

    What is PDEX's forward P/E ratio?

    Pro-Dex has a forward P/E ratio of 21.2x.

    Is PDEX stock overvalued?

    GNG's valuation label for PDEX is Fairly valued. Its P/E of 18.0x compares with a median of 21.7x across 3 similar companies.

    What is PDEX's price to sales ratio?

    Pro-Dex has a price to sales ratio of 2.7x.

    What is Pro-Dex's average P/E ratio over 5 years?

    Pro-Dex's median P/E over the last 5 years is 17.6x, from 60 month-end values through Oct 2026.